Virginia Cancer Specialists Collaborating with Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

Caris Data Further Advances Molecular Understandings of Cancer to Enable the Delivery of Precision Medicine

IRVING, Texas, May 21, 2018 /PRNewswire/ — Caris Life Sciences^®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced the acceptance of 10 abstracts, including one oral presentation, by the American Society of Clinical Oncology (ASCO) for presentation at its annual meeting, being held June 1-5, 2018 in Chicago. The studies were conducted in collaboration with industry-leading academic and clinical institutions across the United States and Europe employing the company’s proprietary Caris Molecular Intelligence^® tumor profiling service.  Read Full Press Release Here